• Fri, March 4, 2022

by: WOPRAI

Corinne Blanchard Maintained (SQM) at Strong Buy with Increased Target to $91 on, Mar 4th, 2022

by: WOPRAI

Joel Jackson Maintained (SQM) at Buy with Increased Target to $100 on, Mar 4th, 2022

by: WOPRAI

Bascome Majors Upgraded (SNDR) to Buy and Held Target at $32 on, Mar 4th, 2022

by: WOPRAI

Frank Morgan Maintained (CHE) at Buy with Decreased Target to $579 on, Mar 4th, 2022

by: WOPRAI

Rick Wise Maintained (TMCI) at Strong Buy with Decreased Target to $32 on, Mar 4th, 2022

by: WOPRAI

Drew Ranieri Maintained (TMCI) at Buy with Decreased Target to $28 on, Mar 4th, 2022

by: WOPRAI

Matt Bottomley Upgraded (TLRY) to Strong Buy and Held Target at $9 on, Mar 4th, 2022

by: WOPRAI

Greg Melich Maintained (TGT) at Hold with Increased Target to $240 on, Mar 4th, 2022

by: WOPRAI

Joshua Wilson Maintained (TGLS) at Strong Buy with Decreased Target to $30 on, Mar 4th, 2022

by: WOPRAI

Eric Handler Upgraded (TTWO) to Strong Buy and Held Target at $200 on, Mar 4th, 2022

by: WOPRAI

James McIlree Maintained (XXII) at Strong Buy and Held Target at $136 on, Mar 4th, 2022

by: WOPRAI

Joseph Altobello Maintained (XPOF) at Strong Buy with Decreased Target to $27 on, Mar 4th, 2022

by: WOPRAI

Robert Dodd Maintained (WHF) at Buy with Decreased Target to $16 on, Mar 4th, 2022

by: WOPRAI

Fawne Jiang Maintained (WB) at Strong Buy with Decreased Target to $56 on, Mar 4th, 2022

by: WOPRAI

Xueru Zhang Upgraded (WB) to Strong Buy and Held Target at $35 on, Mar 4th, 2022

by: WOPRAI

Laura Martin Maintained (VZIO) at Strong Buy with Decreased Target to $16 on, Mar 4th, 2022

by: WOPRAI

Brett Feldman Maintained (VZ) at Strong Buy and Held Target at $61 on, Mar 4th, 2022

by: WOPRAI

Gabriel Moreen Maintained (WES) at Strong Buy with Increased Target to $31 on, Mar 4th, 2022

by: WOPRAI

Andrew Partheniou Downgraded (VFF) to Hold on, Mar 4th, 2022

by: WOPRAI

Brad Reback Maintained (VERI) at Hold with Decreased Target to $23 on, Mar 4th, 2022

by: WOPRAI

Michael Latimore Maintained (VERI) at Buy with Decreased Target to $30 on, Mar 4th, 2022

by: WOPRAI

John Franzreb Maintained (VPG) at Strong Buy with Decreased Target to $48 on, Mar 4th, 2022

by: WOPRAI

Robert Burns Maintained (ADCT) at Strong Buy with Decreased Target to $54 on, Mar 4th, 2022

by: WOPRAI

Jason English Downgraded (ADV) to Hold and Held Target at $7 on, Mar 4th, 2022

by: WOPRAI

Tobey Sommer Maintained (APEI) at Strong Buy with Decreased Target to $26 on, Mar 4th, 2022

by: WOPRAI

Mark Hughes Downgraded (AMSF) to Hold and Held Target at $50 on, Mar 4th, 2022

by: WOPRAI

Patrick Colville Downgraded (AI) to Strong Sell and Decreased Target to $18 on, Mar 4th, 2022

by: WOPRAI

Gary Taylor Maintained (ALHC) at Buy with Decreased Target to $11 on, Mar 4th, 2022

by: WOPRAI

Fawne Jiang Maintained (BILI) at Strong Buy with Decreased Target to $75 on, Mar 4th, 2022

by: WOPRAI

Steve Powers Maintained (BF) at Hold with Decreased Target to $67 on, Mar 4th, 2022

by: WOPRAI

Joseph Feldman Maintained (BBY) at Buy with Increased Target to $130 on, Mar 4th, 2022

by: WOPRAI

Bobby Griffin Downgraded (BBY) to Hold on, Mar 4th, 2022

by: WOPRAI

Steven Forbes Maintained (BBY) at Strong Buy with Decreased Target to $130 on, Mar 4th, 2022

by: WOPRAI

Jonathan Matuszewski Maintained (BBY) at Strong Buy with Increased Target to $140 on, Mar 4th, 2022

by: WOPRAI

Scot Ciccarelli Maintained (BBY) at Hold with Increased Target to $117 on, Mar 4th, 2022

by: WOPRAI

David Long Maintained (ZION) at Strong Buy with Increased Target to $84 on, Mar 4th, 2022

by: WOPRAI

Keay Nakae Maintained (ABUS) at Strong Buy with Increased Target to $6 on, Mar 4th, 2022

by: WOPRAI

Kelly Shi Initiated (ACET) at Strong Buy and Held Target at $27 on, Mar 4th, 2022

by: WOPRAI

Robert Moskow Maintained (BJ) at Buy with Decreased Target to $70 on, Mar 4th, 2022

by: WOPRAI

Dana Telsey Maintained (BURL) at Buy with Decreased Target to $280 on, Mar 4th, 2022

by: WOPRAI

Michael Binetti Maintained (BURL) at Buy with Decreased Target to $245 on, Mar 4th, 2022

by: WOPRAI

Paul Trussell Maintained (BURL) at Strong Buy with Decreased Target to $235 on, Mar 4th, 2022

by: WOPRAI

Kimberly Greenberger Maintained (BURL) at Buy with Decreased Target to $355 on, Mar 4th, 2022

by: WOPRAI

Beth Reed Maintained (BURL) at Strong Buy with Decreased Target to $238 on, Mar 4th, 2022

by: WOPRAI

Mark Altschwager Maintained (BURL) at Buy with Decreased Target to $275 on, Mar 4th, 2022

by: WOPRAI

Bradley Canino Maintained (BPMC) at Strong Buy with Increased Target to $105 on, Mar 4th, 2022

by: WOPRAI

Marisa Hernandez Maintained (BOOM) at Strong Buy with Decreased Target to $41 on, Mar 4th, 2022

by: WOPRAI

Tom White Maintained (CARG) at Hold with Increased Target to $52 on, Mar 4th, 2022

Drew Ranieri Maintained (TMCI) at Buy with Decreased Target to $28 on, Mar 4th, 2022

Drew Ranieri of Morgan Stanley, Maintained "Treace Medical Concepts, Inc." (TMCI) at Buy with Decreased Target from $30 to $28 on, Mar 4th, 2022.

Drew has made no other calls on TMCI in the last 4 months.



There is 1 other peer that has a rating on TMCI. Out of the 1 peers that are also analyzing TMCI, 0 agree with Drew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Drew

  • Danielle Antalffy of "SVB Leerink" Maintained at Buy with Decreased Target to $32 on, Friday, November 5th, 2021

Like: 👍